Patterns of Recurrence in Endometrial Cancer Patients at Risk of Lymph Node Metastasis or Recurrence According to Extent of Lymphadenectomy

2012 ◽  
Vol 22 (4) ◽  
pp. 611-616 ◽  
Author(s):  
Ha-Jeong Kim ◽  
Tae-Joong Kim ◽  
Taejong Song ◽  
Min Kyu Kim ◽  
Yoo-Young Lee ◽  
...  
2017 ◽  
Vol 116 (2) ◽  
pp. 220-226 ◽  
Author(s):  
Glauco Baiocchi ◽  
Carlos Chaves Faloppa ◽  
Henrique Mantoan ◽  
Willian Ricardo Camarço ◽  
Levon Badiglian-Filho ◽  
...  

2018 ◽  
Vol 119 (3) ◽  
pp. 361-369 ◽  
Author(s):  
Jan Kosťun ◽  
Martin Pešta ◽  
Jiří Sláma ◽  
Robert Slunéčko ◽  
Pavel Vlasák ◽  
...  

Author(s):  
Hui-Hua Chen ◽  
Wan-Hua Ting ◽  
Hsu-Dong Sun ◽  
Ming-Chow Wei ◽  
Ho-Hsiung Lin ◽  
...  

Background: to elucidate the predictors of progression-free survival (PFS) and overall survival (OS) in high-risk endometrial cancer patients. Methods: the medical records of all consecutivewomen with high-risk endometrial cancer were reviewed. Results: among 92 high-risk endometrial cancer patients, 30 women experienced recurrence, and 21 women died. The 5-year PFS and OS probabilities were 65.3% and 75.9%, respectively. Multivariable Cox regression revealed that body mass index (hazard ratio (HR) = 1.11), paraaortic lymph node metastasis (HR = 11.11), lymphovascular space invasion (HR = 5.61), and sandwich chemoradiotherapy (HR = 0.15) were independently predictors of PFS. Body mass index (HR = 1.31), paraaortic lymph node metastasis (HR = 32.74), non-endometrioid cell type (HR = 11.31), and sandwich chemoradiotherapy (HR = 0.07) were independently predictors of OS. Among 51 women who underwent sandwich (n = 35) or concurrent (n = 16) chemoradiotherapy, the use of sandwich chemoradiotherapy were associated with better PFS (adjusted HR = 0.26, 95% CI = 0.08–0.87, p = 0.03) and OS (adjusted HR = 0.11, 95% CI = 0.02–0.71, p = 0.02) compared with concurrent chemoradiotherapy. Conclusion: compared with concurrent chemoradiotherapy, sandwich chemoradiotherapy was associated with better PFS and OS in high-risk endometrial cancer patients. In addition, high body mass index, paraaortic lymph node metastasis, and non-endometrioid cell type were also predictors of poor OS in high-risk endometrial cancer patients.


Clinics ◽  
2017 ◽  
Vol 72 (1) ◽  
pp. 30-35 ◽  
Author(s):  
C Anton ◽  
AS Silva ◽  
EC Baracat ◽  
NU Dogan ◽  
C Köhler ◽  
...  

2017 ◽  
Vol 296 (4) ◽  
pp. 803-809 ◽  
Author(s):  
Salih Taşkın ◽  
Yavuz Emre Şükür ◽  
Bulut Varlı ◽  
Kazibe Koyuncu ◽  
Mehmet Murat Seval ◽  
...  

2015 ◽  
Vol 25 (4) ◽  
pp. 657-664 ◽  
Author(s):  
Ayse Altay ◽  
Tayfun Toptas ◽  
Selen Dogan ◽  
Tayup Simsek ◽  
Elif Pestereli

ObjectiveThe aim of this study was to provide detailed knowledge of the metastatic lymph node (LN) locations and to determine factors predicting para-aortic LN metastasis in endometrial cancer patients at risk (intermediate/high) for LN involvement.MethodsA prospective case series with planned data collection was conducted in a total of 173 patients who treated with systematic pelvic para-aortic lymphadenectomy up to the renal vessels. All the LNs removed from pelvic and para-aortic basins—low or high according to the level of the inferior mesenteric artery—were evaluated separately. Logistic regression analyses were performed to determine the impact of variables on para-aortic metastasis.ResultsLymph node metastasis was observed in 21.9% of the patients, pelvic LN involvement in 17.9%, para-aortic LN involvement in 15.0%, both pelvic and para-aortic LN involvement in 10.9%, and isolated para-aortic LN involvement in 4.0%. The most common metastatic LN locations were the external iliac (50.0%), obturator (50.0%), and low precaval regions (36.8%). The least common location of metastasis was the high precaval region (5.3%). Among patients with para-aortic LN metastasis, 42.3% had metastasis above the inferior mesenteric artery. The number of metastatic pelvic LNs greater than or equal to 2 was the only independent predictor of para-aortic metastasis in multivariate analysis (odds ratio, 23.38; 95% confidence interval, 1.35-403.99; P = 0.030), with 96.94% sensitivity, 95.87% specificity, 98.6% positive predictive value, and 97.0% negative predictive value.ConclusionsThe current study supports the idea that in patients at risk of LN involvement, the systematic lymphadenectomy should be performed up to the renal vessels due to the high rate of upper level involvement.


Sign in / Sign up

Export Citation Format

Share Document